MeiHua Holdings Group Co Ltd

600873.CG

Meihua Biological Plans to Register Debt Financing Instruments of Up to 2 Billion Yuan

Meihua Biological announced that its board of directors has reviewed and approved a proposal to apply to the National Association of Financial Market Institutional Investors for registration and issuance of debt financing instruments with a total quota not exceeding 2 billion yuan. Within the registered quota, the company will choose the timing to issue super short-term commercial paper, short-term commercial paper, or medium-term notes, with the funds raised to be used for repaying bank loans and supplementing working capital. This issuance does not include guarantees and still requires approval from the shareholders' meeting and registration approval from the National Association of Financial Market Institutional Investors.

600873.CG

Jiemian·10dRead more →

600873.CG▼

Meihua Biological's 2026 interim net profit was 662 million yuan, down 62.56% year-on-year

Meihua Biological released its 2026 interim report, with net profit attributable to the parent company of 662 million yuan, a decrease of 62.56% compared with the same period last year. The company's total operating revenue was 12.235 billion yuan, a slight decrease of 0.37% year-on-year; net cash inflow from operating activities was 389 million yuan, down 83.17% year-on-year. The company's latest gross margin was 12.93%, a decrease of 10.25 percentage points from the same period last year; diluted earnings per share was 0.24 yuan, down 61.29% year-on-year.

600873.CG ▼

Jiemian·33dRead more →

600873.CG▲

Meihua Biological Releases 2025 Annual Equity Distribution Implementation Announcement, Cash Dividend of 0.4285 Yuan Per Share

Meihua Biological has released its 2025 annual equity distribution implementation announcement, with a cash dividend of 0.4285 yuan per share, including tax. The record date is July 21, 2026, and the ex-dividend and ex-rights date is July 22, 2026. Meihua Biological is a constituent of the Dividend Low Volatility Index, which selects 50 securities with good liquidity, continuous dividends, moderate dividend payout ratios, positive growth in dividends per share, high dividend yields, and low volatility. As of July 15, the Dividend Low Volatility Index had a dividend yield of 4.89 percent over the past year. Since its total return index was launched on December 19, 2013, through the end of May 2026, the probability of a positive return for any six-month holding period was 71 percent, rising to 84 percent, 89 percent, and 95 percent for holding periods of one, two, and three years, respectively. Among investment products tracking this index, the lowest combined management and custody fee is 0.2 percent, with the code 159547.SZ, along with feeder funds A class 021482 and C class 021483.

600873.CG ▲

每日经济新闻·65dRead more →

600873.CG▼

Meihua Group Expects First-Half 2026 Net Profit to Fall 55%–66% Year-on-Year

Meihua Group has disclosed its earnings forecast, expecting net profit attributable to shareholders of 600 million to 800 million yuan for the first half of 2026, a year-on-year decline of 55% to 66%. Deducted non-recurring net profit is projected at 430 million to 630 million yuan, down 61% to 74% year-on-year. The company stated that due to factors such as increased industry supply, prices of major products including monosodium glutamate, threonine, and lysine fell year-on-year, leading to a decline in overall operating profit. The company said it will continue to advance production and cost control, accelerate the deployment of overseas markets and high-value-added products such as pharmaceutical-grade amino acids, and deepen the optimization and upgrading of production capacity structure and processes.

600873.CG ▼

中国证券报·71dRead more →